Kyolic® Formula 101
Natural health product licensed in Canada
- Licence holder
- Wakunaga of America Co., Ltd.
- NPN or DIN-HM
- 80050815
- Status
- Active licence
- Licence date
- 13 May 2014
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine B6: up to 50 mg a day according to the dosing instructions published by Health Canada (4 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 2 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- À vérifier
Vitamine B6: up to 50 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSAEuropean Food Safety Authority. for adults (12 mg a day). Le repère de l'EFSA porte sur l'apport total d'une journée, alimentation et compléments.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitamine B6 | 12.5 mg | 50,000 µg |
| Thiamine | 12.5 mg | 50,000 µg |
| Vitamine B12 | 25 microgrammes | Not calculated |
| Allium sativum Source : Bulbe Extract : Matériel brut sec Extraction ratio : 3:1 Dry plant equivalent : 900 mg | 300 mg | Not calculated |
Non-medicinal ingredients
Gélatine, Cellulose microcristalline, Stéarate de magnésium, Dioxyde de silicium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 2 Capsule | 2 days |
Uses authorised in Canada
A factor in the maintenance of good health. Helps the body to metabolize carbohydrates, fats and proteins. Helps in tissue formation. Helps normal growth. Helps to form red blood cells. Promotes heart health through cholesterol reduction when used in combination with dietary measures. Helps reduce the risk of cardiovascular disease by helping to reduce elevated blood lipid levels/hyperlipidemia in adults. Supports a healthy cardiovascular system. Take as an adjunct to the diet for reduction of elevated total cholesterol. Helps to maintain a healthy lipid profile. Used in Herbal Medicine to help reduce elevated blood lipid levels/ hyperlipidaemia in adults. Used in Herbal Medicine to help maintain cardiovascular health in adults.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Hypersensitivity (e.g. allergy) has been known to occur, in which case discontinue use.
Source
Official Health Canada record, licence 80050815
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.